Atrion revenue

Atrion revenue increased from $146.6 million in 2017 to $152.4 million in 2018, a 4% increase.

Annual Revenue ($)

Atrion revenue was $152.45 m in FY, 2018

Quarterly Revenue ($)

FY, 2015FY, 2016FY, 2017FY, 2018
Revenue$145.73 m$143.49 m$146.60 m$152.45 m
Growth3.53%(1.54%)2.17%
Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019
Revenue$36.22 m$36.14 m$37.84 m$38.50 m$36.16 m$37.90 m$39.40 m$38.85 m$39.27 m$41.61 m$40.10 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Atrion revenue breakdown by business segment: 44.4% from Fluid Delivery, 32.8% from Cardiovascular, 9.2% from Ophthalmology and 13.6% from Other

Atrion revenue breakdown by geographic segment: 63.5% from United States, 5.6% from Germany and 30.9% from Other countries less than 5% of revenues

FY, 2016FY, 2017
Other20.11 m19.93 m
Fluid Delivery60.89 m65.05 m
Cardiovascular47.06 m48.07 m
Ophthalmology15.43 m13.54 m
FY, 2016FY, 2017
United States91.09 m93.08 m
Germany6.40 m8.17 m
Other countries less than 5% of revenues46 m45.34 m